Uterine Fibroid Embolization

UFE is done through a small catheter in the groin or wrist. Tiny particles block blood flow to fibroids, causing them to shrink. The procedure typically takes 30 – 45 minutes and is usually outpatient.

Mild cramping and pelvic discomfort occur for 2–5 days. Most patients resume normal activities within 7–10 days. Heavy lifting is limited for 2 weeks. 85–90% of patients experience significant symptom improvement.

Women with symptomatic fibroids causing heavy bleeding, anemia, pelvic pressure, pain, or urinary issues. Safe for those who want future fertility; some post-menopausal women with persistent symptoms may also be candidates.

Minimally invasive, uterus-preserving, faster recovery, fewer complications, and effective symptom relief in 85–90% of patients.

Rare risks include infection (<1%), non-target embolization, temporary ovarian function changes, and contrast allergy.

Myomectomy, hysterectomy, or medical therapy. UFE offers similar or superior symptom relief with less pain and downtime.

IR provides targeted, minimally invasive treatment, preserves the uterus, and allows faster return to daily life.

Most women do, though bleeding is often lighter.

Symptom relief often occurs within 2–3 months, full effect by 6 months.

Yes, individualized counseling is recommended.

Mild to moderate cramping for 24–48 hours; manageable with medication.

Typically 7 days.

Treated fibroids will not grow back, but untreated fibroids may continue to grow and new fibroids can slowly form over time; 10–15% may need repeat treatment.